Cough

Acute coughs

<3 weeks

Viral URTI, acute bronchitis, COPD, allergic rhinitis, pneumonia, environmental irritants

Subacute

3-8 weeks

Post infections, pneumonia, pertussis, CHF with fluid overload

chronic

UACS, asthma, GERD, COPD, chronic bronchitis

exclusions for cough self treatment

difficulty breathing, cyanosis, hempoptysis, weight loss, night sweats, dyspnea

SOB, cough that worsens of 3-5 days, cough that does not improve after 2-3 weeks, children <4 yo, >100.4

Barking cough, whooping cough, sudden cough, immunocompromised, tuberculosis, HIV, chronic illnesses

OTC remedies indicated for nonproductive coughs

codeine, DXT, chlorphendiol, Diphenhydramine

protussive

guaifenesin

topical antitussives

camphor

menthol

Robotripping is associated with

DXT

This drug is known as purple drank

Promethazine with Codeine

what is the only FDA protussive?

Guaifenesin

Indicated for relief of acute, ineffective productive cough

What are the indications for Guaifenesin

Symptomatic relief of acute, ineffective productive cough

NOT for asthma, COPD, or smoker’s cough

Codeine dosing

Contraindicated in pts <18 yo

menthol interacts with

warfarin

ACCP Guidelines for common cold cough

nonpharmacologic therapy

ACCP Guideline for COVID-19 cough

OTC Antitussives

ACCP guidelines for Postinfectious cough

Nonpharmacologic therapy

Empiric Coughs: 1st gen antihistamine + decongestant with codeine or DXT

ACCP guidelines for UACS

Nonpharmacologic

Empiric (nonallergic): 1st gen antihistamine with or without oral decongestant

Acute bronchitis cough ACCP guideline

nonpharmcologic therapy

ACCP guidelines for cough associated with lower respirpator tract infections

nonpharmacologic + consider cough suppression

Age limit for cough and cold self care

FDA: Do not use in children <2 yo

Consumer Health Care Products: <4 yo